Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PATH: Antioxidant Therapy in Hemodialysis
NCT00237718Phase 2Completed
- Sponsor
- Vanderbilt University
- Start
- Apr 2006
- Primary completion
- Sep 2010
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-lipoic acid, vitamin e in end stage renal disease (ESRD), sponsored by Vanderbilt University. Started Apr 2006; status: completed.
02
Drugs
alpha-lipoic acidvitamin e
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT00237718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237718.